NCT00292344View on ClinicalTrials.gov

Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea

PHASE4CompletedINTERVENTIONAL
Enrollment

316

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

August 31, 2005

Conditions
Travelers' Diarrhea
Interventions
DRUG

Rifaximin and loperamide

Trial Locations (4)

Unknown

Universidad Autonoma de Guadalajara, Guadalajara

University of Arizona, Colegio Guadalajara, Guadalajara

University of San Diego at Iteso, Guadalajara

Clinica Londres Morelos, Cuernavaca

All Listed Sponsors
collaborator

Bausch Health Americas, Inc.

INDUSTRY

lead

The University of Texas Health Science Center, Houston

OTHER

NCT00292344 - Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea | Biotech Hunter | Biotech Hunter